AGENUS INC

Insider Reports History

Location
Lexington, MA
Signature
/s/Christine Klaskin, Vice President, Finance
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by AGENUS INC:

Company Role Class Num Shares Value Price $ Report Date Ownership
MiNK Therapeutics, Inc. 10%+ Owner Common Stock 21,772,863 $22,643,778 $1.04 16 Oct 2023 Direct

Insider Reports Filed by AGENUS INC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INKT MiNK Therapeutics, Inc. 12 Oct 2023 3 $25,270 4 10%+ Owner 16 Oct 2023, 17:49
INKT MiNK Therapeutics, Inc. 04 Oct 2023 1 $16,379 4 10%+ Owner 06 Oct 2023, 16:26
INKT MiNK Therapeutics, Inc. 29 Aug 2023 1 $45,015 4 10%+ Owner 31 Aug 2023, 17:53
INKT MiNK Therapeutics, Inc. 24 Aug 2023 2 $281,478 4 10%+ Owner 28 Aug 2023, 17:15
INKT MiNK Therapeutics, Inc. 10 May 2023 2 $66,643 4 10%+ Owner 12 May 2023, 17:18
INKT MiNK Therapeutics, Inc. 05 May 2023 0 $0 4/A 10%+ Owner 26 May 2023, 17:28
INKT MiNK Therapeutics, Inc. 03 May 2023 4 $260,189 4 10%+ Owner 05 May 2023, 18:00
INKT MiNK Therapeutics, Inc. 01 May 2023 1 $0 4/A 10%+ Owner 26 May 2023, 17:12
INKT MiNK Therapeutics, Inc. 19 Oct 2021 3 $16,800,000 4 10%+ Owner 20 Oct 2021, 19:37
INKT MiNK Therapeutics, Inc. 13 Oct 2021 0 $0 3 10%+ Owner 20 Oct 2021, 19:02